慢性HBV肝损伤修复过程中miR-194的作用及功能研究

基本信息
批准号:81400623
项目类别:青年科学基金项目
资助金额:23.00
负责人:高雪
学科分类:
依托单位:复旦大学
批准年份:2014
结题年份:2017
起止时间:2015-01-01 - 2017-12-31
项目状态: 已结题
项目参与者:Wu Ying,周仲文,王文娟,李琼,李佳丽,孔辉
关键词:
慢乙肝微小RNAmiR194肝损伤
结项摘要

This study aims to discover dynamic changes of microRNA expression in plasma and tissue of chronic hepatitis B (CHB) related liver damage, and to explore mechanism of miR-194 with its target gene ACVR2B during histological liver damage and fibrosis. In our previous experiments, we discovered 9 significantly differential expressed microRNA in plasma of 22 CHB patients and 33 healthy controls using genome-wide microRNA analysis. In 118 plasma and 66 tissue samples of CHB patients, quantitative RT-PCR revealed that expression levels of 6 candidate microRNA (miR-122, miR-192, miR-194, miR-148a, miR-215, miR-27b) in plasma and tissue declined with the aggravation of liver damage and fibrosis. Through analysis of miRecords and KEGG databases, we found that the target genes of 5 candidate microRNA all include activin A receptor genes. There are A、B and AB three subtypes of activin , thereof activin A is most closely with liver . Though combining with receptors, activin A play a role in pathology and physiology process of liver. This implies that these 5 candidate microRNA may regulate hepatocyte apoptosis ,proliferation and liver fibrosis by combining activin A receptors. Based on our recent discoveries, we will establish a liver partial hepatectomy rat model and carbon tetrachloride induced liver fibrosis mice model to observe the expression changes of 5 human-mouse homologous microRNA in plasma and tissue. Through the in vitro and in vivo studies, we will investigate the regulation role and mechanism of key candidate miR-194 and its target gene ACVR2B during the liver damage and fibrosis process. The outcomes in this study will provide the scientific basis for exploring new mechanism of chronic hepatitis B related liver damage.

本项目旨在对慢性HBV肝损伤相关microRNA在血浆和组织中的变化规律及miR-194调节靶基因ACVR2B在肝损伤过程发挥的作用进行研究。我们已在22个慢乙肝患者和33个健康人血浆中进行全基因组microRNA差异表达分析,并通过定量RT-PCR在慢乙肝患者118例血浆及66例肝穿刺组织中验证,得到6个候选microRNA。发现伴随肝脏炎症及纤维化程度的加重血浆和组织中6个候选microRNA的表达逐渐下降。 其中5个microRNA的靶基因均包括了激活素A受体基因。我们推测microRNA通过调节激活素A受体影响肝脏的损伤修复过程。本研究在我们发现的基础上,通过大鼠部分肝切除再生模型以及小鼠慢性肝损伤模型,观察血浆及组织5个人鼠同源microRNA在肝细胞再生以及慢性纤维化过程中的表达变化,并结合细胞实验探索miR-194通过调节AVCR2B对肝细胞增殖和凋亡以及纤维化的影响。

项目摘要

项目成果
{{index+1}}

{{i.achievement_title}}

{{i.achievement_title}}

DOI:{{i.doi}}
发表时间:{{i.publish_year}}

暂无此项成果

数据更新时间:2023-05-31

其他相关文献

1

坚果破壳取仁与包装生产线控制系统设计

坚果破壳取仁与包装生产线控制系统设计

DOI:10.19554/j.cnki.1001-3563.2018.21.004
发表时间:2018
2

MiR-145 inhibits human colorectal cancer cell migration and invasion via PAK4-dependent pathway

MiR-145 inhibits human colorectal cancer cell migration and invasion via PAK4-dependent pathway

DOI:10.1002/cam4.1029.
发表时间:2017
3

Loss of a Centrosomal Protein,Centlein, Promotes Cell Cycle Progression

Loss of a Centrosomal Protein,Centlein, Promotes Cell Cycle Progression

DOI:10.16476/j.pibb.2019.0092
发表时间:2019
4

Complete loss of RNA editing from the plastid genome and most highly expressed mitochondrial genes of Welwitschia mirabilis

Complete loss of RNA editing from the plastid genome and most highly expressed mitochondrial genes of Welwitschia mirabilis

DOI:https://doi.org/10.1007/s11427-018-9450-1
发表时间:2019
5

结直肠癌肝转移患者预后影响

结直肠癌肝转移患者预后影响

DOI:10.3969 /j.issn.1002-266X.2016.23.023
发表时间:2016

高雪的其他基金

批准号:31572376
批准年份:2015
资助金额:64.00
项目类别:面上项目
批准号:81000060
批准年份:2010
资助金额:20.00
项目类别:青年科学基金项目
批准号:21402017
批准年份:2014
资助金额:25.00
项目类别:青年科学基金项目
批准号:11502107
批准年份:2015
资助金额:22.00
项目类别:青年科学基金项目
批准号:31501564
批准年份:2015
资助金额:20.00
项目类别:青年科学基金项目
批准号:41902069
批准年份:2019
资助金额:25.00
项目类别:青年科学基金项目
批准号:81570929
批准年份:2015
资助金额:57.00
项目类别:面上项目

相似国自然基金

1

IL-10调控Th17细胞在慢性HBV感染肝损伤中的作用及机制研究

批准号:81201288
批准年份:2012
负责人:李婕
学科分类:H2103
资助金额:23.00
项目类别:青年科学基金项目
2

肝脏GABA能系统调控肝枯否细胞功能在慢性HBV感染小鼠肝内HBV特异性CD8+ T细胞耗竭中的作用及其机制

批准号:81873865
批准年份:2018
负责人:王双连
学科分类:H1103
资助金额:57.00
项目类别:面上项目
3

HLA-DR/DQ等位在慢性HBV感染免疫损伤中的作用及机制研究

批准号:81330038
批准年份:2013
负责人:邓国宏
学科分类:H2103
资助金额:290.00
项目类别:重点项目
4

HMGB1在HBV复制和乙肝肝损伤中的作用研究

批准号:81071339
批准年份:2010
负责人:吴传新
学科分类:H2103
资助金额:35.00
项目类别:面上项目